Total Payments
$404.38
2023 Payments
$82.20
Companies
14
Transactions
29
Medicare Patients
4,411
Medicare Billing
$299,064
Payment Breakdown by Category
Food & Beverage$354.38 (87.6%)
Other$50.00 (12.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $354.38 | 28 | 87.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50.00 | 1 | 12.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $77.86 | 6 | $0 (2018) |
| PFIZER INC. | $68.27 | 5 | $0 (2023) |
| Becton, Dickinson and Company | $50.00 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $38.16 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $34.56 | 3 | $0 (2018) |
| AbbVie Inc. | $25.74 | 2 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $21.45 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.48 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $13.28 | 1 | $0 (2018) |
| Novo Nordisk Inc | $13.08 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $82.20 | 3 | Becton, Dickinson and Company ($50.00) |
| 2021 | $25.74 | 2 | AbbVie Inc. ($25.74) |
| 2019 | $12.07 | 1 | PFIZER INC. ($12.07) |
| 2018 | $138.02 | 11 | Allergan Inc. ($37.93) |
| 2017 | $146.35 | 12 | Allergan Inc. ($39.93) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/26/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Obesity | ||||||
| 03/21/2023 | Becton, Dickinson and Company | BD SafetyGlide (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $50.00 | General |
| Category: Catheter Care and Medication Delivery | ||||||
| 08/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2019 | PFIZER INC. | EUCRISA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: DERMATOLOGY | ||||||
| 09/13/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 07/19/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: DIABETES | ||||||
| 05/23/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Respiratory | ||||||
| 05/22/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/11/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2018 | Allergan Inc. | BYVALSON (Drug), BYSTOLIC | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/15/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/08/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: RESPIRATORY | ||||||
| 02/05/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/03/2018 | Allergan Inc. | BYVALSON (Drug), BYSTOLIC | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/30/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/26/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.28 | General |
| Category: AED | ||||||
| 09/28/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/14/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: DIABETES | ||||||
| 08/31/2017 | Purdue Pharma L.P. | OXYCONTIN (Drug) | Food and Beverage | Cash or cash equivalent | $12.75 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/30/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 946 | 1,115 | $178,784 | $50,585 |
| 2022 | 15 | 1,233 | 1,541 | $291,940 | $89,586 |
| 2021 | 18 | 1,088 | 1,418 | $223,567 | $79,079 |
| 2020 | 21 | 1,144 | 1,465 | $203,719 | $79,815 |
Total Patients
4,411
Total Services
5,539
Medicare Billing
$299,064
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 124 | 135 | $63,450 | $15,375 | 24.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 115 | 126 | $31,500 | $9,939 | 31.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 87 | 157 | $26,636 | $8,419 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 134 | 146 | $16,936 | $6,398 | 37.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 52 | $12,636 | $4,422 | 35.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 260 | 298 | $11,026 | $1,743 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 22 | $3,696 | $1,529 | 41.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 19 | 19 | $3,192 | $1,138 | 35.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 18 | 18 | $5,670 | $583.44 | 10.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 51 | 51 | $1,530 | $428.72 | 28.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 51 | 51 | $1,632 | $367.54 | 22.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 40 | 40 | $880.00 | $242.55 | 27.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 153 | 164 | $76,660 | $23,696 | 30.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 164 | 366 | $62,060 | $18,987 | 30.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 166 | 180 | $44,904 | $13,651 | 30.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 69 | 71 | $30,120 | $9,439 | 31.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 64 | 82 | $19,893 | $6,160 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 124 | 139 | $15,290 | $6,026 | 39.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 53 | 54 | $9,140 | $2,649 | 29.0% |
| 99236 | Hospital observation or inpatient care admitted and discharged on the same day for high severity problem, typically 55 minutes | Facility | 2022 | 12 | 12 | $6,024 | $1,881 | 31.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 30 | 37 | $6,270 | $1,787 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 23 | $3,680 | $1,624 | 44.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 218 | 251 | $8,785 | $1,571 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,320 | $633.32 | 48.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 15 | 15 | $4,230 | $474.19 | 11.2% |
About Dr. Scott Jarvis, M.D
Dr. Scott Jarvis, M.D is a Gastroenterology healthcare provider based in Van Wert, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760466692.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Jarvis, M.D has received a total of $404.38 in payments from pharmaceutical and medical device companies, with $82.20 received in 2023. These payments were reported across 29 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($354.38).
As a Medicare-enrolled provider, Jarvis has provided services to 4,411 Medicare beneficiaries, totaling 5,539 services with total Medicare billing of $299,064. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Sleep Medicine, Internal Medicine
- Location Van Wert, OH
- Active Since 12/05/2005
- Last Updated 03/25/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1760466692
Products in Payments
- BD SafetyGlide (Device) $50.00
- VIBERZI (Drug) $28.18
- BYVALSON (Drug) $26.27
- LYRICA (Drug) $25.98
- UBRELVY (Drug) $25.74
- FARXIGA (Drug) $22.22
- ELIQUIS (Drug) $19.12
- TRELEGY ELLIPTA (Drug) $15.08
- STIOLTO (Drug) $14.48
- ENTRESTO (Drug) $13.28
- Wegovy (Drug) $13.08
- OXYCONTIN (Drug) $12.75
- ASMANEX (Drug) $12.67
- SYMBICORT (Drug) $12.34
- EUCRISA (Drug) $12.07
- ANORO (Drug) $11.78
- BYSTOLIC (Drug) $11.75
- VRAYLAR (Drug) $11.66
- TROKENDI XR (Drug) $11.28
- CHANTIX (Drug) $11.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.